Shlomo Keidar - Concepedia

Author

Shlomo Keidar

Rappaport Family Institute for Research in the Medical Sciences

Also Known As

Keidar Shlomo, SHLOMO KEIDAR, Shlomo Keidar

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

Rappaport Family Institute for Research in the Medical Sciences Rambam Health Care Campus Technion – Israel Institute of Technology Carmel Medical Center

About

Shlomo Keidar is an author at Rappaport Family Institute for Research in the Medical Sciences specializing in medicine, vascular biology, and atherosclerosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	31	2.1K
2	Health Sciences	8	8	705
3	Public Health	5	5	181
4	Natural Sciences	1	1	25
5	Anesthesia	1	1	18

Shlomo Keidar

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Vitamin E Supplementation Reduces Cardiovascular Events in a Subgroup of Middle-Aged Individuals With Both Type 2 Diabetes Mellitus and the Haptoglobin 2-2 Genotype Uzi Milman, Shany Blum, Chen Shapira, Arteriosclerosis Thrombosis and Vascular Biology	2007	278
Aldosterone Administration to Mice Stimulates Macrophage NADPH Oxidase and Increases Atherosclerosis Development Shlomo Keidar, Marielle Kaplan, Elsa Pavlotzky, Circulation	2004	240
Mineralocorticoid Receptor Blocker Increases Angiotensin-Converting Enzyme 2 Activity in Congestive Heart Failure Patients Shlomo Keidar, Aviva Gamliel-Lazarovich, Marielle Kaplan, Circulation Research HypertensionHeart FailureSpironolactone TherapyLipid PeroxidationCardiovascular Pharmacology	2005	200
Reduced susceptibility of low density lipoprotein (LDL) to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL Osamah Hussein, Sorina Schlezinger, Mira Rosenblat, Atherosclerosis Low Density LipoproteinMetabolic SyndromeHypocholesterolemic EffectCardiovascular DiseaseMedicine	1997	177
Angiotensin II stimulates macrophage-mediated oxidation of low density lipoproteins Shlomo Keidar, Marielle Kaplan, Aharon Hoffman, Atherosclerosis InflammationAngiotensin IiLipid PeroxidationPhysiologyImmunology	1995	150
The Angiotensin-II Receptor Antagonist, Losartan, Inhibits LDL Lipid Peroxidation and Atherosclerosis in Apolipoprotein E-Deficient Mice Shlomo Keidar, Judith Attias, Jonathan D. Smith, Biochemical and Biophysical Research Communications Metabolic SyndromeAngiotensin-ii Receptor AntagonistCardiovascular DiseaseBiochemistryMedicine	1997	138
Atorvastatin therapy in hypercholesterolemic patients suppresses cellular uptake of oxidized-LDL by differentiating monocytes Bianca Fuhrman, Lena Koren, Nina Volkova, Atherosclerosis InflammationOxysterolHypercholesterolemic PatientsCardiovascular DiseaseCellular Uptake	2002	133
Effect of Eplerenone, a Selective Aldosterone Blocker, on Blood Pressure, Serum and Macrophage Oxidative Stress, and Atherosclerosis in Apolipoprotein E–Deficient Mice Shlomo Keidar, Tony Hayek, Marielle Kaplan, Journal of Cardiovascular Pharmacology	2003	127
Interactions of Platelets, Macrophages, and Lipoproteins in Hypercholesterolemia: Antiatherogenic Effects of HMG-CoA Reductase Inhibitor Therapy Michael Aviram, Osamah Hussein, Mira Rosenblat, Journal of Cardiovascular Pharmacology Platelet Cholesterol ContentHyperlipidemiaPlatelet AggregationOxidative StressThrombosis	1998	119
Angiotensin II Administration to Atherosclerotic Mice Increases Macrophage Uptake of Oxidized LDL Shlomo Keidar, Ronit Heinrich, Marielle Kaplan, Arteriosclerosis Thrombosis and Vascular Biology	2001	113

Page 1